Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""gp41"" wg kryterium: Temat


Tytuł :
Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation.
Autorzy :
Jette CA; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Barnes CO; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Kirk SM; Department of Chemistry, University of Pennsylvania, Philadelphia, PA, USA.
Melillo B; Department of Chemistry, University of Pennsylvania, Philadelphia, PA, USA.
Smith AB 3rd; Department of Chemistry, University of Pennsylvania, Philadelphia, PA, USA.
Bjorkman PJ; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Mar 29; Vol. 12 (1), pp. 1950. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
CD4 Antigens/*chemistry
Guanidines/*chemistry
HIV Envelope Protein gp120/*chemistry
HIV Envelope Protein gp41/*chemistry
HIV-1/*chemistry
Indenes/*chemistry
Receptors, Virus/*chemistry
Animals ; Binding Sites ; Biomimetic Materials/chemistry ; Biomimetic Materials/metabolism ; CD4 Antigens/antagonists & inhibitors ; CD4 Antigens/genetics ; CD4 Antigens/metabolism ; CHO Cells ; Cloning, Molecular ; Cricetulus ; Cryoelectron Microscopy ; Gene Expression ; Genetic Vectors/chemistry ; Genetic Vectors/metabolism ; Guanidines/metabolism ; HEK293 Cells ; HIV Envelope Protein gp120/genetics ; HIV Envelope Protein gp120/metabolism ; HIV Envelope Protein gp41/genetics ; HIV Envelope Protein gp41/metabolism ; HIV-1/metabolism ; Humans ; Indenes/metabolism ; Models, Molecular ; Protein Binding ; Protein Conformation, alpha-Helical ; Protein Conformation, beta-Strand ; Protein Interaction Domains and Motifs ; Protein Multimerization ; Receptors, Virus/antagonists & inhibitors ; Receptors, Virus/genetics ; Receptors, Virus/metabolism ; Recombinant Proteins/chemistry ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/metabolism
Czasopismo naukowe
Tytuł :
The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
Autorzy :
Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC 27710.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
Filsinger Interrante MV; Stanford Medical Scientist Training Program, Stanford University School of Medicine, Stanford, CA 94305.; Stanford Biophysics Program, Stanford University School of Medicine, Stanford, CA 94305.; Stanford ChEM-H, Stanford University, Stanford, CA 94305.
Bell BN; Stanford ChEM-H, Stanford University, Stanford, CA 94305.; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305.
Rubio AA; Stanford ChEM-H, Stanford University, Stanford, CA 94305.; Department of Biology, Stanford University School of Humanities and Sciences, Stanford, CA 94305.
Joyce JG; Vaccine Process Development, Merck & Co., Inc., West Point, PA 19486.
Shiver JW; Department of Vaccine Basic Research, Merck Research Laboratories, West Point, PA 19486.
LaBranche CC; Department of Surgery, Duke University Medical Center, Durham, NC 27710.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
Kim PS; Stanford ChEM-H, Stanford University, Stanford, CA 94305; .; Department of Biochemistry, Stanford University School of Medicine, Stanford, CA 94305.; Chan Zuckerberg Biohub, San Francisco, CA 94158.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Jan 19; Vol. 118 (3).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
HIV Envelope Protein gp41/*immunology
HIV Infections/*drug therapy
Receptors, IgG/*immunology
Repetitive Sequences, Amino Acid/*genetics
Amino Acid Sequence ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Neutralizing/pharmacology ; Antibody Affinity ; Guinea Pigs ; HIV Antibodies/immunology ; HIV Antibodies/pharmacology ; HIV Envelope Protein gp41/genetics ; HIV Infections/genetics ; HIV Infections/immunology ; HIV Infections/virology ; HIV Seropositivity/immunology ; HIV-1/drug effects ; HIV-1/immunology ; HIV-1/pathogenicity ; Humans ; Immune Sera/immunology ; Immune Sera/pharmacology ; Immunization ; Immunoglobulin G/immunology ; Repetitive Sequences, Amino Acid/immunology ; Virus Internalization/drug effects
Czasopismo naukowe
Tytuł :
Structure, membrane topology and influence of cholesterol of the membrane proximal region: transmembrane helical anchor sequence of gp41 from HIV.
Autorzy :
Aisenbrey C; Institut de chimie de Strasbourg, UMR7177, University of Strasbourg/CNRS, 4, Rue Blaise Pascal, 67070, Strasbourg, France.
Rifi O; Institut de chimie de Strasbourg, UMR7177, University of Strasbourg/CNRS, 4, Rue Blaise Pascal, 67070, Strasbourg, France.
Bechinger B; Institut de chimie de Strasbourg, UMR7177, University of Strasbourg/CNRS, 4, Rue Blaise Pascal, 67070, Strasbourg, France. .; Institut Universitaire de France, Paris, France. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Dec 17; Vol. 10 (1), pp. 22278. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cholesterol/*chemistry
HIV Envelope Protein gp41/*ultrastructure
HIV Infections/*genetics
HIV-1/*ultrastructure
Amino Acid Sequence/genetics ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/genetics ; HIV Infections/physiopathology ; HIV Infections/virology ; HIV-1/chemistry ; Humans ; Peptides/chemistry ; Peptides/genetics ; Protein Structure, Secondary
Czasopismo naukowe
Tytuł :
Bivalent HIV-1 fusion inhibitors based on peptidomimetics.
Autorzy :
Kobayakawa T; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Ebihara K; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Tsuji K; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Kawada T; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Fujino M; AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Honda Y; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Ohashi N; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Murakami T; AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan. Electronic address: .
Tamamura H; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University (TMDU), 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan. Electronic address: .
Pokaż więcej
Źródło :
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2020 Dec 15; Vol. 28 (24), pp. 115812. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Peptidomimetics*
HIV Envelope Protein gp41/*chemistry
HIV Fusion Inhibitors/*chemistry
Dimerization ; Disulfides/chemistry ; Drug Design ; HIV Envelope Protein gp41/metabolism ; HIV Fusion Inhibitors/metabolism ; HIV Fusion Inhibitors/pharmacology ; HIV-1/drug effects ; HIV-1/metabolism ; Humans ; Peptides/chemistry ; Polyethylene Glycols/chemistry
Czasopismo naukowe
Tytuł :
Biophysical studies of HIV-1 glycoprotein-41 interactions with peptides and small molecules - Effect of lipids and detergents.
Autorzy :
Zhou G; Department of Basic Sciences, College of Osteopathic Medicine, Touro University California, Vallejo, CA 94592, United States of America.
Chu S; Department of Basic Sciences, College of Osteopathic Medicine, Touro University California, Vallejo, CA 94592, United States of America.
Kohli A; Department of Bioengineering and Therapeutic Sciences, UCSF School of Pharmacy, San Francisco, CA 94143, United States of America.
Szoka FC; Department of Bioengineering and Therapeutic Sciences, UCSF School of Pharmacy, San Francisco, CA 94143, United States of America; Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, San Francisco, CA 94143, United States of America.
Gochin M; Department of Basic Sciences, College of Osteopathic Medicine, Touro University California, Vallejo, CA 94592, United States of America; Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, San Francisco, CA 94143, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2020 Dec; Vol. 1864 (12), pp. 129724. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Detergents/*metabolism
HIV Envelope Protein gp41/*metabolism
HIV-1/*metabolism
Phospholipids/*metabolism
Small Molecule Libraries/*metabolism
Cholesterol/metabolism ; HIV Envelope Protein gp41/chemistry ; HIV Infections/drug therapy ; HIV Infections/virology ; HIV-1/chemistry ; Humans ; Lipid Bilayers/metabolism ; Liposomes/metabolism ; Models, Molecular ; Protein Binding ; Protein Unfolding
Czasopismo naukowe
Tytuł :
Selection and immune recognition of HIV-1 MPER mimotopes.
Autorzy :
Wieczorek L; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD, 20817, USA; Catholic University of America, 620 Michigan Ave NE, Washington, DC, 20064, USA.
Peachman K; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD, 20817, USA.
Steers N; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD, 20817, USA.
Schoen J; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, 6720A Rockledge Drive, Bethesda, MD, 20817, USA.
Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA.
Polonis V; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD, 20910, USA.
Rao V; Catholic University of America, 620 Michigan Ave NE, Washington, DC, 20064, USA. Electronic address: .
Pokaż więcej
Źródło :
Virology [Virology] 2020 Nov; Vol. 550, pp. 99-108. Date of Electronic Publication: 2020 Sep 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Epitopes/*chemistry
HIV Antibodies/*biosynthesis
HIV Envelope Protein gp41/*chemistry
HIV Infections/*prevention & control
HIV-1/*immunology
HIV-2/*immunology
AIDS Vaccines/administration & dosage ; Amino Acid Sequence ; Animals ; Antibodies, Monoclonal/biosynthesis ; Antibodies, Neutralizing/biosynthesis ; Antibody Specificity ; Antigens, Viral/chemistry ; Antigens, Viral/immunology ; Antigens, Viral/metabolism ; Binding, Competitive ; Enzyme-Linked Immunosorbent Assay ; Epitope Mapping ; Epitopes/immunology ; Epitopes/metabolism ; Female ; HIV Envelope Protein gp41/immunology ; HIV Envelope Protein gp41/metabolism ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/genetics ; HIV-2/drug effects ; HIV-2/genetics ; Humans ; Immunity, Humoral/drug effects ; Immunization/methods ; Mice ; Mice, Inbred BALB C ; Peptide Library ; Peptides/chemistry ; Peptides/immunology ; Peptides/metabolism ; Protein Binding
Czasopismo naukowe
Tytuł :
Roles of variable linker length in dual acting virucidal entry inhibitors on HIV-1 potency via on-the-fly free energy molecular simulations.
Autorzy :
Gossert ST; Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania, USA.
Parajuli B; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Chaiken I; Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania, USA.
Abrams CF; Department of Chemical and Biological Engineering, Drexel University, Philadelphia, Pennsylvania, USA.; Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
Pokaż więcej
Źródło :
Protein science : a publication of the Protein Society [Protein Sci] 2020 Nov; Vol. 29 (11), pp. 2304-2310. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Molecular Dynamics Simulation*
HIV Envelope Protein gp41/*chemistry
HIV-1/*chemistry
Lectins/*chemistry
Recombinant Fusion Proteins/*chemistry
HIV Envelope Protein gp41/genetics ; HIV-1/genetics ; Lectins/genetics ; Recombinant Fusion Proteins/genetics ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Neutralizing Antibodies Targeting HIV-1 gp41.
Autorzy :
Caillat C; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Guilligay D; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Sulbaran G; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Weissenhorn W; Institut de Biologie Structurale (IBS), University Grenoble Alpes, Commissariat à L'énergie Atomique et Aux Énergies Alternatives (CEA), Centre National de la Recherche Scientifique (CNRS), 38000 Grenoble, France.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 Oct 23; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antibodies, Neutralizing/*chemistry
Antibodies, Neutralizing/*immunology
HIV Antibodies/*immunology
HIV Envelope Protein gp41/*immunology
AIDS Vaccines/immunology ; Animals ; Epitopes/immunology ; HIV Envelope Protein gp41/genetics ; HIV-1/genetics ; HIV-1/immunology ; Humans ; Mice ; Mutation
Czasopismo naukowe
Tytuł :
Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.
Autorzy :
Das R; Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Datta R; Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Varadarajan R; Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India .; Jawaharlal Nehru Center for Advanced Scientific Research, Bangalore, India.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Oct 14; Vol. 94 (21). Date of Electronic Publication: 2020 Oct 14 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Amino Acid Substitution*
Aspartic Acid/*chemistry
HIV Envelope Protein gp120/*chemistry
HIV Envelope Protein gp160/*chemistry
HIV Envelope Protein gp41/*chemistry
HIV-1/*genetics
Aspartic Acid/metabolism ; CD4 Antigens/genetics ; CD4 Antigens/metabolism ; Cloning, Molecular ; Gene Expression ; Genetic Vectors/chemistry ; Genetic Vectors/metabolism ; HEK293 Cells ; HIV Envelope Protein gp120/genetics ; HIV Envelope Protein gp120/metabolism ; HIV Envelope Protein gp160/genetics ; HIV Envelope Protein gp160/metabolism ; HIV Envelope Protein gp41/genetics ; HIV Envelope Protein gp41/metabolism ; HIV-1/metabolism ; Humans ; Intrinsically Disordered Proteins/chemistry ; Intrinsically Disordered Proteins/genetics ; Intrinsically Disordered Proteins/metabolism ; Mutagenesis ; Protein Multimerization ; Protein Stability ; Proteolysis ; Recombinant Proteins/chemistry ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism
Czasopismo naukowe
Tytuł :
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates.
Autorzy :
Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
van Schooten J; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bowman CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Yuan M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Oyen D; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Shin M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Morpurgo R; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van der Woude P; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Breemen M; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Patel R; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Gross J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Copps J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
Nogal B; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
Sok D; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.
Rakasz EG; Wisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, United States of America.
Labranche C; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.
Vigdorovich V; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Christley S; Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas, United States of America.
Carnathan DG; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Sather DN; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Montefiori D; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Silvestri G; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Burton DR; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America.
Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America.
Sanders RW; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, California, United States of America.
van Gils MJ; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2020 Aug 31; Vol. 16 (8), pp. e1008753. Date of Electronic Publication: 2020 Aug 31 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Epitope Mapping*
AIDS Vaccines/*immunology
Epitopes/*immunology
HIV Antibodies/*immunology
HIV Envelope Protein gp120/*immunology
HIV Envelope Protein gp41/*immunology
HIV-1/*immunology
AIDS Vaccines/genetics ; Animals ; Antibodies, Monoclonal, Murine-Derived/immunology ; Epitopes/genetics ; HIV Antibodies/genetics ; HIV Envelope Protein gp41/genetics ; HIV-1/genetics ; Macaca mulatta ; Protein Multimerization/genetics ; Protein Multimerization/immunology
Czasopismo naukowe
Tytuł :
Subnanometer structures of HIV-1 envelope trimers on aldrithiol-2-inactivated virus particles.
Autorzy :
Li Z; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.; Microbial Sciences Institute, Yale University, West Haven, CT, USA.; Fudan University Shanghai Cancer Center, Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Li W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.; Microbial Sciences Institute, Yale University, West Haven, CT, USA.
Lu M; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.
Bess J Jr; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Chao CW; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Gorman J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Terry DS; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Zhang B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Zhou T; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Blanchard SC; Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Mothes W; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA. .
Liu J; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA. .; Microbial Sciences Institute, Yale University, West Haven, CT, USA. .
Pokaż więcej
Źródło :
Nature structural & molecular biology [Nat Struct Mol Biol] 2020 Aug; Vol. 27 (8), pp. 726-734. Date of Electronic Publication: 2020 Jun 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms :
2,2'-Dipyridyl/*analogs & derivatives
Disulfides/*pharmacology
HIV Envelope Protein gp120/*chemistry
HIV Envelope Protein gp41/*chemistry
HIV-1/*drug effects
Virion/*drug effects
2,2'-Dipyridyl/pharmacology ; Cell Line ; Cryoelectron Microscopy ; Electron Microscope Tomography ; HIV Envelope Protein gp120/ultrastructure ; HIV Envelope Protein gp41/ultrastructure ; HIV Infections/virology ; HIV-1/chemistry ; Humans ; Models, Molecular ; Oxidants/pharmacology ; Protein Conformation/drug effects ; Protein Multimerization/drug effects ; Solubility ; Virion/chemistry
Czasopismo naukowe
Tytuł :
Cholesterol Interaction with the Trimeric HIV Fusion Protein gp41 in Lipid Bilayers Investigated by Solid-State NMR Spectroscopy and Molecular Dynamics Simulations.
Autorzy :
Kwon B; Department of Chemistry, Massachusetts Institute of Technology, 170 Albany Street, Cambridge, MA 02139, USA.
Mandal T; Department of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA.
Elkins MR; Department of Chemistry, Massachusetts Institute of Technology, 170 Albany Street, Cambridge, MA 02139, USA.
Oh Y; Department of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA.
Cui Q; Department of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA; Department of Physics, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA; Department of Biomedical Engineering, Boston University, 590 Commonwealth Avenue, Boston, MA 02215, USA.
Hong M; Department of Chemistry, Massachusetts Institute of Technology, 170 Albany Street, Cambridge, MA 02139, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of molecular biology [J Mol Biol] 2020 Jul 24; Vol. 432 (16), pp. 4705-4721. Date of Electronic Publication: 2020 Jun 24.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Mutation*
Cholesterol/*metabolism
HIV Envelope Protein gp41/*chemistry
HIV Envelope Protein gp41/*metabolism
HIV-1/*metabolism
Amino Acid Sequence ; Binding Sites ; Biomimetic Materials/metabolism ; HIV Envelope Protein gp41/genetics ; HIV-1/genetics ; Lipid Bilayers/metabolism ; Magnetic Resonance Spectroscopy ; Models, Molecular ; Molecular Dynamics Simulation ; Protein Binding ; Protein Domains ; Protein Structure, Secondary ; Virus Internalization
Czasopismo naukowe
Tytuł :
Polyethylene Glycol 40-Modified Peptide with High Therapeutic Efficacy in Simian-Human Immunodeficiency Virus-Acutely Infected Rhesus Monkeys.
Autorzy :
Li M; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Chaoyang District, Beijing, China.; Savaid Medical School, University of Chinese Academy of Sciences, Huairou District, Beijing, China.
Cheng S; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Chaoyang District, Beijing, China.; Savaid Medical School, University of Chinese Academy of Sciences, Huairou District, Beijing, China.
Ding Y; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Changping District, Beijing, China.
Wang C; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Changping District, Beijing, China.
Feng Y; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Chaoyang District, Beijing, China.; Savaid Medical School, University of Chinese Academy of Sciences, Huairou District, Beijing, China.
Wang W; State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Chaoyang District, Beijing, China.
Ma L; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Changping District, Beijing, China .
Li X; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Chaoyang District, Beijing, China .; Savaid Medical School, University of Chinese Academy of Sciences, Huairou District, Beijing, China.
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Jul 01; Vol. 94 (14). Date of Electronic Publication: 2020 Jul 01 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Envelope Protein gp41*/chemistry
HIV Envelope Protein gp41*/pharmacokinetics
HIV Envelope Protein gp41*/pharmacology
HIV Fusion Inhibitors*/chemistry
HIV Fusion Inhibitors*/pharmacokinetics
HIV Fusion Inhibitors*/pharmacology
HIV Infections*/drug therapy
HIV Infections*/metabolism
HIV Infections*/pathology
Peptide Fragments*/chemistry
Peptide Fragments*/pharmacokinetics
Peptide Fragments*/pharmacology
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Acquired Immunodeficiency Syndrome*/metabolism
Simian Acquired Immunodeficiency Syndrome*/pathology
HIV-1/*metabolism
Polyethylene Glycols/*chemistry
Simian Immunodeficiency Virus/*metabolism
Animals ; Humans ; Macaca mulatta
Czasopismo naukowe
Tytuł :
Structure, interactions and membrane topology of HIV gp41 ectodomain sequences.
Autorzy :
Aisenbrey C; Université de Strasbourg/CNRS, UMR7177, Institut de Chimie, 4, Rue Blaise Pascal, 67070 Strasbourg, France.
Bechinger B; Université de Strasbourg/CNRS, UMR7177, Institut de Chimie, 4, Rue Blaise Pascal, 67070 Strasbourg, France; Institut Universitaire de France, France. Electronic address: .
Pokaż więcej
Źródło :
Biochimica et biophysica acta. Biomembranes [Biochim Biophys Acta Biomembr] 2020 Jul 01; Vol. 1862 (7), pp. 183274. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Envelope Protein gp41/*ultrastructure
HIV Infections/*genetics
HIV-1/*genetics
Membrane Fusion/*genetics
Cell Membrane/genetics ; Cell Membrane/virology ; HIV Envelope Protein gp41/chemistry ; HIV Envelope Protein gp41/genetics ; HIV Infections/virology ; HIV-1/pathogenicity ; Humans ; Magnetic Resonance Spectroscopy ; Peptide Fragments/chemistry ; Peptide Fragments/genetics ; Protein Conformation
Czasopismo naukowe
Tytuł :
Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
Autorzy :
Joshi VR; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Department of Virology, Harvard Medical School, Boston, Massachusetts, United States of America.
Newman RM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Pack ML; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Power KA; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Munro JB; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
Okawa K; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Madani N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Sodroski JG; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Schmidt AG; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America.
Allen TM; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.
Pokaż więcej
Źródło :
PLoS pathogens [PLoS Pathog] 2020 May 11; Vol. 16 (5), pp. e1008577. Date of Electronic Publication: 2020 May 11 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Envelope Protein gp41*/antagonists & inhibitors
HIV Envelope Protein gp41*/immunology
Antibodies, Neutralizing/*pharmacology
HIV Antibodies/*pharmacology
HIV Infections/*immunology
HIV-1/*immunology
Virus Internalization/*drug effects
Antibodies, Neutralizing/immunology ; CD4 Antigens/immunology ; HEK293 Cells ; HIV Antibodies/immunology ; HIV Infections/drug therapy ; HIV Infections/pathology ; Humans
Czasopismo naukowe
Tytuł :
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes.
Autorzy :
Xiao T; Division of Molecular Medicine, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Frey G; Division of Molecular Medicine, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; ICCB-Longwood Screening Facility, Harvard Medical School, Boston, MA, USA.
Fu Q; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Lavine CL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Scott DA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Chou JJ; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Chen B; Division of Molecular Medicine, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA. .
Pokaż więcej
Źródło :
Nature chemical biology [Nat Chem Biol] 2020 May; Vol. 16 (5), pp. 529-537. Date of Electronic Publication: 2020 Mar 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Anti-HIV Agents/*chemistry
Anti-HIV Agents/*pharmacology
HIV Envelope Protein gp41/*chemistry
HIV Envelope Protein gp41/*metabolism
Virus Internalization/*drug effects
Binding Sites ; CD4 Antigens/metabolism ; Cell Membrane/metabolism ; Dequalinium/chemistry ; Dequalinium/pharmacology ; Drug Evaluation, Preclinical/methods ; Fluorescence Polarization ; HEK293 Cells ; HIV Envelope Protein gp41/genetics ; HIV-1/pathogenicity ; Humans ; Hydrophobic and Hydrophilic Interactions ; Magnetic Resonance Spectroscopy ; Molecular Structure ; Mutation ; Small Molecule Libraries/chemistry ; Small Molecule Libraries/pharmacology ; Structure-Activity Relationship ; Surface Plasmon Resonance
Czasopismo naukowe
Tytuł :
Development of a RPLC-UV method for monitoring uncleaved HIV-1 envelope glycoprotein.
Autorzy :
Schneck NA; Vaccine Production Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Gaithersburg, MD 20878, USA. .
Vinitsky AL
Ivleva VB
Wang X
Gowetski DB
Lei QP
Pokaż więcej
Źródło :
Analytical methods : advancing methods and applications [Anal Methods] 2021 May 21; Vol. 13 (19), pp. 2183-2188. Date of Electronic Publication: 2021 May 06.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms :
HIV-1*/genetics
env Gene Products, Human Immunodeficiency Virus*
Antigens, Viral ; HIV Envelope Protein gp41/genetics ; Molecular Conformation
Czasopismo naukowe
Tytuł :
Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effects.
Autorzy :
Jurado S; Departamento de Química Física, Instituto de Biotecnología e Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
Cano-Muñoz M; Departamento de Química Física, Instituto de Biotecnología e Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
Polo-Megías D; Departamento de Química Física, Instituto de Biotecnología e Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain.
Conejero-Lara F; Departamento de Química Física, Instituto de Biotecnología e Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain. Electronic address: .
Morel B; Departamento de Química Física, Instituto de Biotecnología e Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente (UEQ), Facultad de Ciencias, Universidad de Granada, 18071 Granada, Spain. Electronic address: .
Pokaż więcej
Źródło :
Archives of biochemistry and biophysics [Arch Biochem Biophys] 2020 Jul 30; Vol. 688, pp. 108401. Date of Electronic Publication: 2020 May 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Envelope Protein gp41/*metabolism
HIV-1/*chemistry
Peptide Fragments/*metabolism
Amino Acid Motifs ; Amino Acid Sequence ; Calorimetry ; HIV Envelope Protein gp41/chemistry ; Peptide Fragments/chemistry ; Protein Binding ; Recombinant Fusion Proteins/chemistry ; Recombinant Fusion Proteins/metabolism ; Thermodynamics
Czasopismo naukowe
Tytuł :
Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.
Autorzy :
Mediouni S; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Jablonski JA; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Tsuda S; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Barsamian A; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA.
Kessing C; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Richard A; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Biswas A; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Toledo F; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Andrade VM; University of Miami Miller School of Medicine, Miami, Florida, USA.
Even Y; The Botanist's Beach Farm, Hobe Sound, Florida, USA.
Stevenson M; University of Miami Miller School of Medicine, Miami, Florida, USA.
Tellinghuisen T; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Choe H; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
Cameron M; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA.
Bannister TD; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA.
Valente ST; Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Jul 16; Vol. 94 (15). Date of Electronic Publication: 2020 Jul 16 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Cymenes/*pharmacology
HIV Envelope Protein gp41/*metabolism
HIV-1/*metabolism
Origanum/*chemistry
Plant Oils/*pharmacology
Virus Internalization/*drug effects
Animals ; Cholesterol/genetics ; Cholesterol/metabolism ; Cymenes/chemistry ; Drug Resistance, Viral ; HIV Envelope Protein gp41/genetics ; HIV Infections/drug therapy ; HIV Infections/genetics ; HIV Infections/metabolism ; HIV-1/genetics ; HeLa Cells ; Humans ; Macaca mulatta ; Mutation ; Plant Oils/chemistry
Czasopismo naukowe
Tytuł :
Unsaturated Lipid Accelerates Formation of Oligomeric β-Sheet Structure of GP41 Fusion Peptide in Model Cell Membrane.
Autorzy :
Wang W; Hefei National Laboratory for Physical Sciences at the Microscale, and Department of Chemical Physics, University of Science and Technology of China, Hefei, Anhui 230026, P. R. China.
Tan J; Hefei National Laboratory for Physical Sciences at the Microscale, and Department of Chemical Physics, University of Science and Technology of China, Hefei, Anhui 230026, P. R. China.
Ye S; Hefei National Laboratory for Physical Sciences at the Microscale, and Department of Chemical Physics, University of Science and Technology of China, Hefei, Anhui 230026, P. R. China.
Pokaż więcej
Źródło :
The journal of physical chemistry. B [J Phys Chem B] 2020 Jun 25; Vol. 124 (25), pp. 5169-5176. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Envelope Protein gp41*
Membrane Fusion*
Protein Structure, Secondary*
Amino Acid Sequence ; Cell Membrane ; Humans ; Lipid Bilayers ; Lipids ; Peptides ; Protein Conformation, beta-Strand
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies